XWELL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 05:05 pm EST
Share
XWELL, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 10.74 million compared to USD 26.77 million a year ago. Net loss was USD 7.18 million compared to net income of USD 5.6 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to basic earnings per share from continuing operations of USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to diluted earnings per share from continuing operations of USD 0.05 a year ago.
For the nine months, revenue was USD 48.38 million compared to USD 44.37 million a year ago. Net loss was USD 19.38 million compared to net income of USD 0.074 million a year ago. Basic loss per share from continuing operations was USD 0.2. Diluted loss per share from continuing operations was USD 0.2.
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and HyperPointe. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck wellness centers in airports, to airport employees and to the traveling public. Its Treat segment provides access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place, as well as book appointments in the Companyâs on-site wellness centers as they reopen. HyperPointe segment provides a range of service and support options for its customers, including technical support services and advanced services.